Skip to main content
    A

    Amgen Inc (AMGN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $457.93
    -4.39 (-0.95%)

    Market Cap: $250.07B

    Last updated: Nov 17, 2026 at 4:44 PM ET

    Amgen Inc (AMGN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Amgen (AMGN) has a market cap of $250.07B and an enterprise value of $290.89B. Its trailing P/E of 19.8x is above its 10-year median of 14.3x.

    Total Valuation

    Enterprise value is 16.32% above the market cap, as debt exceeds cash.

    Market Cap$250.07B
    Enterprise Value$290.89B
    Latest price (Nov 17, 2026)$457.93

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 20, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Next Ex-Dividend DateNov 20, 2026
    Next Payment DateDec 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.19% in the quarter ended Sep 30, 2026 and grew 0.37% a year over 2 years.

    Shares Outstanding541.00M
    Shares Change (YoY)+0.56%
    Shares Change (QoQ)+0.19%
    Share Count Growth (2Y CAGR)+0.37%

    Valuation Ratios

    Sales and book value multiples are 6.4x and 17.3x. Its year-end P/E ranged from 12.6x to 16.3x from 2016 to 2025.

    P/E Ratio19.8x
    Forward P/E19.1x
    P/S Ratio6.4x
    Forward P/S6.3x
    P/B Ratio17.3x
    P/FCF Ratio25.9x
    P/OCF Ratio20.8x
    PEG Ratio3.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.9x EBITDA and 30.1x free cash flow.

    EV / Earnings31.0x
    EV / Sales7.5x
    EV / EBITDA15.9x
    EV / EBIT21.3x
    EV / FCF30.1x

    Price Statistics

    The stock is up 37.88% over 52 weeks and trades 7.22% above its 50-day average.

    Beta (1Y)0.50
    52-Week Change+37.88%
    1-Month Change+7.76%
    3-Month Change+4.11%
    6-Month Change+39.25%
    5-Year Change+125.16%
    10-Year Change+230.13%
    Total Return (1Y)+40.88%
    Total Return (3Y CAGR)+22.15%
    Total Return (5Y CAGR)+20.42%
    Return vs SPY (1Y)+23.42%
    Max Drawdown (1Y)-17.04%
    Max Drawdown (3Y)-22.73%
    Sharpe Ratio (1Y)1.05
    Correlation with SPY (1Y)0.24
    50-Day Average$427.10
    200-Day Average$380.10
    52-Week Range$306.13 to $483.99
    RSI (14 Days)55.3
    Average Volume (20 Days)2.65M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.48x current liabilities, and total debt is 3.76x shareholder equity.

    Current Ratio1.48x
    Quick Ratio1.20x
    Debt / Equity3.76x
    Debt / EBITDA2.97x
    Debt / FCF5.64x
    Interest Coverage5.19x

    Returns and Efficiency

    Return on invested capital is 17.01% over the last 12 months, against a 5-year average of 15.00%.

    Return on Equity (ROE)65.43%
    Return on Assets (ROA)9.78%
    Return on Invested Capital (ROIC)17.01%
    Return on Capital Employed (ROCE)18.80%
    ROE (5Y Average)106.67%
    ROA (5Y Average)7.92%
    ROIC (5Y Average)15.00%
    Asset Turnover0.42x
    Inventory Turnover1.80x
    Receivables Turnover3.78x
    Cash Conversion Cycle206 days

    Taxes

    Income tax took 15.03% of pretax income over the last 12 months.

    Income Tax (TTM)$1.66B
    Effective Tax Rate15.03%

    Scores

    AMGN has an Altman Z-Score of 2.55, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.55
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $38.90B over the last 12 months is up 8.15% from the 12 months before.

    Revenue$38.90B
    Revenue Growth (YoY)+8.15%
    Gross Profit$27.58B
    Operating Income$12.61B
    Pretax Income$11.05B
    Net Income$9.39B
    EBITDA$18.17B
    EBIT$13.69B
    Reported EPS (TTM)$23.18

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 14.94% of the $96.05B in total assets.

    Cash and Equivalents$13.19B
    Total Debt$54.01B
    Net Debt$40.82B
    Net Debt Per Share$75.45
    Working Capital$11.13B
    Shareholder Equity$14.35B
    Book Value Per Share$26.53
    Tangible Book Value-$23.85B
    Total Assets$96.05B
    Total Liabilities$81.70B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.45B of capital spending, operating cash flow left $9.58B of free cash flow.

    Operating Cash Flow$12.04B
    Capital Expenditures$2.45B
    Free Cash Flow$9.58B
    FCF Per Share$17.72
    Depreciation and Amortization$4.48B
    Dividends Paid$5.37B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 32.41%, against a 5-year average of 28.04%.

    Gross Margin70.90%
    Operating Margin32.41%
    Pretax Margin28.41%
    Net Margin24.14%
    EBITDA Margin46.71%
    EBIT Margin35.18%
    FCF Margin24.63%
    Gross Margin (5Y Average)69.92%
    Operating Margin (5Y Average)28.04%
    Net Margin (5Y Average)20.92%

    Growth

    Revenue grew 11.77% a year over 3 years, and EPS 7.29% a year.

    Revenue Growth (3Y CAGR)+11.77%
    Revenue Growth (5Y CAGR)+7.65%
    EPS Growth (3Y CAGR)+7.29%
    EPS Growth (5Y CAGR)+5.65%
    FCF Growth (3Y CAGR)-2.67%
    FCF Growth (5Y CAGR)-3.91%
    Operating Income Growth (3Y CAGR)-1.72%
    Book Value Per Share Growth (2Y CAGR)+17.54%

    Revenue and profit by year

    Dividends and Yields

    AMGN pays out 44.68% of earnings as dividends.

    Dividend Per Share (Annual)$10.08
    Dividend Yield2.20%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+7.05%
    Dividend Growth (5Y CAGR)+8.27%
    Payout Ratio44.68%
    FCF Payout Ratio56.01%
    Earnings Yield5.05%
    FCF Yield3.87%
    Shareholder Yield2.17%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Nov 22, 1999.

    Last Split DateNov 22, 1999
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 9 similar companies, AMGN has the 6th highest P/E.

    P/E Ratio19.8x vs 21.3x median
    P/S Ratio6.4x vs 4.1x median
    ROIC17.01% vs 12.84% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.15% vs +5.31% median
    Dividend Yield2.20% vs 2.69% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.99% and EPS growth at 7.08% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.99%
    EPS Growth Forecast (2Y CAGR)+7.08%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AMGN

    What is AMGN's market cap?

    Amgen has a market cap of $250.07B. Its enterprise value, which adds debt and subtracts cash, is $290.89B.

    What is AMGN's P/E ratio?

    Amgen has a trailing P/E ratio of 19.8x and a forward P/E of 19.1x.

    How many shares of AMGN are outstanding?

    Amgen has 541.00M shares outstanding. The count is up 0.56% from a year earlier.

    Does AMGN pay a dividend?

    Yes. Amgen pays $10.08 a share a year, a dividend yield of 2.20%.

    How much debt does AMGN have?

    Amgen has $54.01B of total debt and $13.19B of cash and equivalents, a net debt position of $40.82B.